HSTOQ (Histogen) OCF Margin %: -53,780.00% (As of Sep. 2023)


HSTOQ Histogen Inc HSTOQ
12 GF Score
Price $0.00
View Full Analysis

What is Histogen OCF Margin %?

Histogen HSTOQ +316.67% 12 OCF Margin % is -53,780.00% as of Sep. 2023. GuruFocus rates HSTOQ with a GF Score™ of 12/100.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Histogen's Cash Flow from Operations for the three months ended in Sep. 2023 was $-2.69 Mil. Histogen's Revenue for the three months ended in Sep. 2023 was $0.01 Mil. Therefore, Histogen's OCF Margin % for the quarter that ended in Sep. 2023 was -53,780.00%.

As of today, Histogen's current OCF Yield % is -201,480.00%.

The historical rank and industry rank for Histogen's OCF Margin % or its related term are showing as below:

HSTOQ' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -53021.05

HSTOQ's OCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -66.52 vs HSTOQ: -53021.05

Histogen OCF Margin % Related Terms

Histogen OCF Margin % Historical Data

* Premium members only.

The historical data trend for Histogen's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Histogen OCF Margin % Chart

Histogen Annual Data
Trend Dec19 Dec20 Dec21 Dec22
OCF Margin %
-11.42 -585.43 -1,581.28 -256.91

Histogen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -49,000.00 -60,975.00 -51,000.00 -47,920.00 -53,780.00

HSTOQ vs GLMD, BLCM, NBY: OCF Margin % Comparison

For the Biotechnology subindustry, Histogen's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Histogen OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Histogen's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Histogen's OCF Margin % falls into.


HSTOQ
12GF Score
Histogen Inc HSTOQ
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Histogen OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Histogen's OCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-9.683/3.769
=-256.91 %

Histogen's OCF Margin for the quarter that ended in Sep. 2023 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-2.689/0.005
=-53,780.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -53,780.00% mean?
Histogen (HSTOQ) has a OCF Margin % of -53,780.00% as of Sep. 2023. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Histogen and its competitors.
Is Histogen's OCF Margin % too high?
Histogen's current OCF Margin % is -53,780.00%. Overall, Histogen has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Histogen's OCF Margin % compare to GLMD and BLCM?
Histogen's OCF Margin % of -53,780.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Histogen and its competitors. Histogen's current OCF Margin % is -53,780.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Histogen stock overvalued right now?
Histogen (HSTOQ) has a current OCF Margin % of -53,780.00%. The current OCF Margin % is -53,780.00%. Histogen's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Histogen (HSTOQ), the current OCF Margin % is -53,780.00% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Histogen Business Description

Address 10655 Sorrento Valley Road, Suite 200, San Diego, CA, USA, 92121
Histogen Inc is a clinical-stage therapeutics company focused on developing proprietary hypoxia-generated growth factor technology platforms and stem cell-free biologic products as potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Under its biologics technology platform, the product candidates in development are HST-003, a treatment for joint cartilage repair, and HST-004, a treatment for spinal disc repair. It also has a pipeline of clinical and preclinical small molecule pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases that the company intends to develop.
12GF Score

Get the complete analysis for HSTOQ

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price